Mauna Kea Technologies (Euronext: MKEA, FR0010609263; OTCQX: MKEAY), inventor of Cellvizio(R), the multidisciplinary confocal laser endomicroscopy platform, today announced its full-year results for the financial year ended December 31, 2015, as approved by the Board of Directors at its meeting on March 23, 2016. Benoît Jacheet, Chief Financial Officer of Mauna Kea Technologies, stated: "2015 was a critical year in the implementation of our updated strategic plan and this affected our sales performance. Even so, we successfully delivered a significant improvement in our gross margin and operating performance by streamlining our cost structure to reduce fixed operating costs. Increased financial flexibility is expected to support the continued growth of our global user base." As previously reported, Mauna Kea Technologies recorded a 22% decline in its full-year 2015 sales to EUR8,547 thousand.